{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:30:41Z","timestamp":1785796241078,"version":"3.56.0"},"reference-count":7,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0378-6323.155567","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T09:09:43Z","timestamp":1429607383000},"page":"311","source":"Crossref","is-referenced-by-count":3,"title":["Cutaneous involvement of marginal zone B-lymphoma noted after topical imiquimod; more than a coincidence?"],"prefix":"10.25259","volume":"81","author":[{"given":"Tamara","family":"Gracia-Caza\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Aul\u00e9s-Leonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel\u00c1ngel","family":"Marigil-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Gilaberte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.155567-1","first-page":"467","volume-title":"Beyond a decade of 5% imiquimod topical therapy","author":"Gaspari","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0378-6323.155567-2","first-page":"3768","volume-title":"WHO-EORTC classification for cutaneous lymphomas","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"key-10.4103\/0378-6323.155567-3","first-page":"142","volume-title":"Cutaneous involvement with marginal zone lymphoma","author":"Gerami","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.155567-4","first-page":"684","volume-title":"Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas","author":"Pereira","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0378-6323.155567-5","first-page":"412","volume-title":"High Incidence of Gastrointestinal Tract Disorders and Autoimmunity in Primary Cutaneous Marginal Zone B-Cell Lymphomas","author":"Guitart","year":"2014","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/0378-6323.155567-6","first-page":"e75","volume-title":"Development of adenopathy during the use of topical imiquimod","author":"Anadkat","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.155567-7","first-page":"566","volume-title":"Gastric extranodal marginal zone B-cell lymphomas of MALT type exclusively express Toll-like receptor 4 in contrast to other lymphomas infiltrating the stomach","author":"Adam","year":"2008","journal-title":"Ann Oncol"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:38:05Z","timestamp":1612658285000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/cutaneous-involvement-of-marginal-zone-b-lymphoma-noted-after-topical-imiquimod-more-than-a-coincidence\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"alternative-id":["155567"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.155567","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}